Hepatitis C drug injury

FDA Issues Drug Injury Warning Regarding Two Hepatitis C Medications

by Norris Injury Lawyers | October 27th, 2015

Hepatitis C is a viral disease that can last a lifetime and cause damage to the liver that can ultimately results in organs failure. Medications can help treat this disease, but the drug injury attorneys at Norris Injury Lawyers would like to warn patients about the use of certain drugs.

An article from WSFA 12 News explains the U.S. Food and Drug Administration (FDA) has issued warnings regarding two medications used to treat Hepatitis C, Viekira Pak and Technivie. Officials say using these products may cause patients suffering from advanced liver disease to develop serious liver damage.

As many as 26 cases of patients experiencing adverse side effects associated with the drugs has been reported worldwide. Of those cases, a total of 10 patients died or required a liver transplant. Another 16 patients developed some form of liver dysfunction within weeks of beginning to take the medication.

The FDA has issued warnings to users of these products to be aware of the risks. Patients taking Viekira Pak or Technivie should not stop taking the drug without consulting a physician first. If you experience fatigue, weakness, loss of appetite, nausea, vomiting, yellowing of the eyes or skin, or light-colored stools, you may want to speak with your doctor, as these may be signs of liver damage.

The Alabama personal injury lawyers at Norris Injury Lawyers hope this information helps to protect you and your loved ones from the harm certain medications may cause.